Clover Health Investments Corp (CLOV) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.51 is considered Undervalued compared with the five-year average of -11.78. The fair price of Clover Health Investments Corp (CLOV) is between 2.72 to 3.79 according to relative valuation method. Compared to the current price of 2.04 USD , Clover Health Investments Corp By Undervalued By 25.02%.

Relative Value

Fair Zone

2.72-3.79

Current Price：2.04

25.02%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Clover Health Investments Corp (CLOV) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Clover Health Investments Corp (CLOV) has a current Price-to-Book (P/B) ratio of 3.63. Compared to its 3-year average P/B ratio of 3.17, the current P/B ratio is approximately 14.76% higher. Relative to its 5-year average P/B ratio of 3.67, the current P/B ratio is about -1.07% higher. Clover Health Investments Corp (CLOV) has a Forward Free Cash Flow (FCF) yield of approximately -6.94%. Compared to its 3-year average FCF yield of -18.69%, the current FCF yield is approximately -62.88% lower. Relative to its 5-year average FCF yield of -17.59%, the current FCF yield is about -60.56% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CLOV competitors is 0.97, providing a benchmark for relative valuation. Clover Health Investments Corp Corp (CLOV.O) exhibits a P/S ratio of 0.51, which is -47.43% above the industry average. Given its robust revenue growth of 50.05%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CLOV increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CLOV in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CLOV currently overvalued or undervalued?

Clover Health Investments Corp (CLOV) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.51 is considered Undervalued compared with the five-year average of -11.78. The fair price of Clover Health Investments Corp (CLOV) is between 2.72 to 3.79 according to relative valuation method. Compared to the current price of 2.04 USD, Clover Health Investments Corp is Undervalued By 25.02%.

What is Clover Health Investments Corp (CLOV) fair value?

CLOV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Clover Health Investments Corp (CLOV) is between 2.72 to 3.79 according to relative valuation method.

How does CLOV's valuation metrics compare to the industry average?

The average P/S ratio for CLOV's competitors is 0.97, providing a benchmark for relative valuation. Clover Health Investments Corp Corp (CLOV) exhibits a P/S ratio of 0.51, which is -47.43% above the industry average. Given its robust revenue growth of 50.05%, this premium appears sustainable.

What is the current P/B ratio for Clover Health Investments Corp (CLOV) as of Mar 03 2026?

As of Mar 03 2026, Clover Health Investments Corp (CLOV) has a P/B ratio of 3.63. This indicates that the market values CLOV at 3.63 times its book value.

What is the current FCF Yield for Clover Health Investments Corp (CLOV) as of Mar 03 2026?

As of Mar 03 2026, Clover Health Investments Corp (CLOV) has a FCF Yield of -6.94%. This means that for every dollar of Clover Health Investments Corp's market capitalization, the company generates -6.94 cents in free cash flow.

What is the current Forward P/E ratio for Clover Health Investments Corp (CLOV) as of Mar 03 2026?

As of Mar 03 2026, Clover Health Investments Corp (CLOV) has a Forward P/E ratio of -30.16. This means the market is willing to pay $-30.16 for every dollar of Clover Health Investments Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Clover Health Investments Corp (CLOV) as of Mar 03 2026?

As of Mar 03 2026, Clover Health Investments Corp (CLOV) has a Forward P/S ratio of 0.51. This means the market is valuing CLOV at $0.51 for every dollar of expected revenue over the next 12 months.

CLOV Valuation